Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [(18)F]FEPPA.

Hafizi S, Tseng H-H, Rao N, Selvanathan T, Kenk M, Bazinet RP, et al. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [(18)F]FEPPA. Am J Psychiatry. 2017;174(2):118-124. DOI: 10.1176/appi.ajp.2016.16020171. PubMed PMID: 27609240.

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.

Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry. 2004;161(9):1709-11. DOI: 10.1176/appi.ajp.161.9.1709. PubMed PMID: 15337666.

Psychiatric comorbidities and schizophrenia.

Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35(2):383-402. DOI: 10.1093/schbul/sbn135. PubMed PMID: 19011234.

Comparison of Subjective Experiences and Effectiveness of First-Generation Long-Acting Injectable Antipsychotics and Risperidone Long-Acting Injectables in Patients With Schizophrenia.

Chen W-Y, Lin S-K. Comparison of Subjective Experiences and Effectiveness of First-Generation Long-Acting Injectable Antipsychotics and Risperidone Long-Acting Injectables in Patients With Schizophrenia. J Clin Psychopharmacol. 2016;36(5):492-5. DOI: 10.1097/JCP.0000000000000555. PubMed PMID: 27580495.

Life-Threatening Lupus-Like Syndrome Associated With Clozapine.

Buzina N, Eterović M. Life-Threatening Lupus-Like Syndrome Associated With Clozapine. J Clin Psychopharmacol. 2016;36(5):532-4. DOI: 10.1097/JCP.0000000000000550. PubMed PMID: 27580496.

Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia.

Young-Xu Y, Duh MS, Muser E, DerSarkissian M, Faust E, Kageleiry A, et al. Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia. J Clin Psychiatry. 2016;77(10):e1332-e1341. DOI: 10.4088/JCP.16m10745. PubMed PMID: 27574835.

Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia.

Nasrallah HA, Newcomer JW, Risinger R, Du Y, Zummo J, Bose A, et al. Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia. J Clin Psychiatry. 2016;77(11):1519-1525. DOI: 10.4088/JCP.15m10467. PubMed PMID: 27574838.

Irving Gottesman.

Snyder A. Irving Gottesman. Lancet. 2016;388(10045):654. PubMed PMID: 27551696.

Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.

Conley RR, Love RC, Kelly DL, Bartko JJ. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. AJP. 1999;156(6):863-8. DOI: 10.1176/ajp.156.6.863. PubMed PMID: 10360124.

Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine.

Werneck AP, Hallak JC, Nakano E, Elkis H. Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine. Psychiatry Res. 2011;188(3):315-9. DOI: 10.1016/j.psychres.2011.04.004. PubMed PMID: 21596442.